Table 5
Impact of diagnostic techniques on the treatment of pulmonary infiltrates5-150
| Diagnostic technique |
No positive/ no performed (%) |
Modification of treatment, n (%) |
| Blood cultures | 30/191 (16%) | 4 (5%) |
| CMV antigen detection | 11/91 (12%) | 5 (5%) |
| Aspergillus antigen detection | 8/54 (15%) | 1 (1%) |
| NPW | 9/50 (18%) | 1 (1%) |
| Sputum | 27/88 (31%) | 11 (12%) |
| FBAS | 16/28 (57%) | 4 (4%) |
| TBAS | 35/55 (64%) | 24 (26%) |
| PSB | 30/125 (24%) | 2 (2%) |
| BAL | 68/135 (51%) | 35 (38%) |
| TBB | 6/11 (55%) | 4 (4%) |
| VTC biopsy | 2/2 (100%) | 2 (2%) |
-
NPW = nasopharyngeal wash; FBAS = fibrobronchial aspirate; TBAS = tracheobronchial aspirate; PSB = protected specimen brush; BAL = bronchoalveolar lavage; TBB = transbronchial biopsy; VTC = videothoracoscopic.
-
↵5-150 In some patients treatment changes were due to the results obtained with several diagnostic procedures simultaneously.
